JP2021517139A5 - - Google Patents
Info
- Publication number
- JP2021517139A5 JP2021517139A5 JP2020547139A JP2020547139A JP2021517139A5 JP 2021517139 A5 JP2021517139 A5 JP 2021517139A5 JP 2020547139 A JP2020547139 A JP 2020547139A JP 2020547139 A JP2020547139 A JP 2020547139A JP 2021517139 A5 JP2021517139 A5 JP 2021517139A5
- Authority
- JP
- Japan
- Prior art keywords
- ophthalmic composition
- inflammation
- allergic conjunctivitis
- composition according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862641094P | 2018-03-09 | 2018-03-09 | |
| US62/641,094 | 2018-03-09 | ||
| US201862663999P | 2018-04-27 | 2018-04-27 | |
| US62/663,999 | 2018-04-27 | ||
| PCT/US2019/021402 WO2019173744A1 (en) | 2018-03-09 | 2019-03-08 | Methods of use and pharmaceutical compositions of a selective syk inhibitor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021517139A JP2021517139A (ja) | 2021-07-15 |
| JP2021517139A5 true JP2021517139A5 (https=) | 2022-03-10 |
| JP7417531B2 JP7417531B2 (ja) | 2024-01-18 |
Family
ID=65818744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020547139A Active JP7417531B2 (ja) | 2018-03-09 | 2019-03-08 | 選択的ｓｙｋ阻害剤の使用方法および医薬組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210052582A1 (https=) |
| EP (1) | EP3761986A1 (https=) |
| JP (1) | JP7417531B2 (https=) |
| KR (1) | KR20210018193A (https=) |
| CN (2) | CN112243375A (https=) |
| AU (1) | AU2019230220B2 (https=) |
| BR (1) | BR112020018377A2 (https=) |
| CA (1) | CA3093371A1 (https=) |
| IL (1) | IL277093A (https=) |
| MX (1) | MX2020009396A (https=) |
| PH (1) | PH12020551418A1 (https=) |
| SG (1) | SG11202008765UA (https=) |
| TW (1) | TWI805705B (https=) |
| WO (1) | WO2019173744A1 (https=) |
| ZA (1) | ZA202005459B (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009514969A (ja) * | 2005-11-09 | 2009-04-09 | コンビナトアールエックス インコーポレーティッド | 医学的状態を治療するための方法、組成物、およびキット |
| AU2007227091B2 (en) | 2006-03-17 | 2013-02-07 | Johnson & Johnson Vision Care, Inc. | Stabilized ophthalmic compositions comprising oxidatively unstable components |
| SG165655A1 (en) * | 2008-04-16 | 2010-11-29 | Portola Pharm Inc | 2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or JAK kinases inhibitors |
| US8063058B2 (en) * | 2008-04-16 | 2011-11-22 | Portola Pharmaceuticals, Inc. | Inhibitors of syk and JAK protein kinases |
| AU2012351948A1 (en) * | 2011-12-16 | 2014-07-10 | Allergan, Inc. | Ophthalmic compositions comprising polyvinyl capralactam - polyvinyl acetate - polyethylene glycol graft copolymer |
| AR090650A1 (es) * | 2012-04-12 | 2014-11-26 | Alcon Res Ltd | Tratamiento para respuestas inflamatorias inducidas por microbios en el ojo |
| WO2014045029A1 (en) * | 2012-09-18 | 2014-03-27 | Ziarco Pharma Ltd | 2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors |
-
2019
- 2019-03-08 BR BR112020018377-6A patent/BR112020018377A2/pt not_active Application Discontinuation
- 2019-03-08 JP JP2020547139A patent/JP7417531B2/ja active Active
- 2019-03-08 WO PCT/US2019/021402 patent/WO2019173744A1/en not_active Ceased
- 2019-03-08 MX MX2020009396A patent/MX2020009396A/es unknown
- 2019-03-08 CA CA3093371A patent/CA3093371A1/en active Pending
- 2019-03-08 AU AU2019230220A patent/AU2019230220B2/en active Active
- 2019-03-08 KR KR1020207028762A patent/KR20210018193A/ko active Pending
- 2019-03-08 CN CN201980017916.9A patent/CN112243375A/zh active Pending
- 2019-03-08 TW TW108107933A patent/TWI805705B/zh not_active IP Right Cessation
- 2019-03-08 SG SG11202008765UA patent/SG11202008765UA/en unknown
- 2019-03-08 US US16/979,075 patent/US20210052582A1/en not_active Abandoned
- 2019-03-08 EP EP19712475.3A patent/EP3761986A1/en active Pending
- 2019-03-08 CN CN202411182880.9A patent/CN119235862A/zh active Pending
-
2020
- 2020-09-01 IL IL277093A patent/IL277093A/en unknown
- 2020-09-01 ZA ZA2020/05459A patent/ZA202005459B/en unknown
- 2020-09-09 PH PH12020551418A patent/PH12020551418A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019232153B2 (en) | Ophthalmic formulation | |
| JP5956735B2 (ja) | Ｐ２ｙ２受容体作動薬およびヒアルロン酸またはその塩を組み合わせたことを特徴とするドライアイ治療剤 | |
| CA2806942C (en) | Compounds for the treatment/prevention of ocular inflammatory diseases | |
| JP2022502421A5 (https=) | ||
| RU2632107C2 (ru) | Пероральная фармацевтическая композиция для профилактики или лечения синдрома "сухого глаза", содержащая ребамипид или его предшественник | |
| JP2011527339A5 (https=) | ||
| KR101778004B1 (ko) | 이마티닙을 유효성분으로 포함하는 안구 건조 질환 예방 및 치료용 약학 조성물 | |
| JP2005145961A (ja) | 角結膜障害の治療剤 | |
| CN102105167A (zh) | 轴性近视的预防或治疗剂 | |
| JP6267003B2 (ja) | ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤 | |
| JP7038437B2 (ja) | 眼障害及び皮膚疾患の処置のための化合物、組成物、及び方法 | |
| JP2024516929A5 (https=) | ||
| JP2022520832A5 (https=) | ||
| JP2021517139A5 (https=) | ||
| WO2019024433A1 (zh) | 氨基金刚烷胺单硝酸酯类化合物眼用组合物及其制剂和应用 | |
| RU2019118904A (ru) | Распределение в глазу и фармакокинетика композиций лифитеграста | |
| WO2018056268A1 (ja) | 炎症性眼疾患の治療及び／又は予防剤 | |
| FI4329725T3 (fi) | Isosyklosporiini a silmäsairauksien paikalliseen hoitoon | |
| US20090082455A1 (en) | Therapeutic agent for ophthalmic disease | |
| JP7417531B2 (ja) | 選択的ｓｙｋ阻害剤の使用方法および医薬組成物 | |
| US20180221417A1 (en) | Treatment of dry eye using amnion released factors | |
| JP4778515B2 (ja) | 角膜疾患治療剤 | |
| WO2026027718A1 (en) | Cxcl8 inhibitors for use in the treatment of ocular graft-versus-host disease | |
| EP4351540A1 (en) | Trpa1 channel antagonist compound for use in degenerative retinal diseases | |
| WO2007066678A1 (ja) | 角結膜障害治療剤 |